
Emerging evidence suggests that the risk of maternal mortality was more than 10-times greater among those with COVID-19 infection.

Emerging evidence suggests that the risk of maternal mortality was more than 10-times greater among those with COVID-19 infection.

Susan Koletar, MD, FACP, FIDSA, director of the Division of Infectious Diseases at the Ohio State University College of Medicine, discusses the pharmacists’ role in addressing vaccine hesitancy and improving global vaccine rates.

A linear mixed-effect model for repeated estimated glomerular filtration rate measurements at baseline and a follow-up visit, up to 5 years after baseline, shows results.

41% of patients report moderate-to-severe issues, with Black individuals 3 times more likely to develop these difficulties.

Remote services allow unrivaled opportunities for outreach to vulnerable populations and those in rural areas.

For chronic cases, encourage patients to seek medical care from their primary health care providers.

Pharmacy students must understand the intricacies of culture and health, but they first need to be aware of their biases and prejudices.

Pharmacy professionals can bring in the right people at the right time to identify needed changes and develop an action plan.

The risk of a second stroke after intracerebral hemorrhage (ICH) did not differ by index hematoma location, and this risk was higher for ischemic stroke than ICH.

Patients administered anakinra did not meet a study’s primary endpoint of proportion of patients who did not need mechanical ventilation 15 days after starting treatment for severe COVID-19 pneumonia.

But analysis does suggest a small increase in risk for individuals who used cigarettes and electronic nicotine delivery systems together.

Limiting added or free sugar is recommended to reduce the adverse effects, especially in cardiometabolic disease.

During the 12-month trial period, Hyqvia was shown to be efficacious treating the occurrence of acute serious bacterial infections in children aged 2 through 16 years with primary immunodeficiency.

Pharmacists serve as advocates to optimize patient pharmaceutical care, advance the profession, and positively influence the community.

The FDA’s temporary Guidance for 503A compounding of shortage drugs was meant to be temporary and withdrawn once COVID-19 ended.

Availability of clinical trials in the gynecologic cancer care space are increasing, but it is important to be mindful of current racial disparities.

Keeping blood glucose levels within a target range delays prevents serious health complications associated with type 2 diabetes.

The risk is particularly high in the first 2 years after an HIV diagnosis.

The role of monoclonal antibodies in minimizing COVID-19–related complications remains important to assess.

To build a brighter, healthier, and more equitable future for all US citizens, there is an indisputable need to decriminalize psychedelic medicines.

Analysis indicates that there was a larger increase of filled prescriptions for individuals who delivered by cesarean birth.

These are used to help reduce inappropriate testing, where an expert consults with medical directors of infection prevention and control for a test-order override.

Pharmacy benefit managers offer mentorship, training opportunities, and professional advancement beyond what's available in traditional pharmacy careers.

Pharmacists are crucial in supporting patients with attention-deficit hyperactivity disorder as shortages of Adderall continue.

It is important for pharmacists to educate patients, especially those with cardiovascular risks, about the differences between fish oil supplements and prescription n3-FAs products.

It is still unclear whether comorbidities have similar negative effects on cognition beyond those directly caused by obstructive sleep apnea.

Taken together, the studies point to meaningful changes in the standard of care for patients with advanced or recurrent endometrial cancer.

Individuals treated with the drugs from AstraZeneca demonstrate clinically meaningful and statistically significant improvement.

State-level respiratory syncytial virus hospitalization rates for 2022 could be the highest seen since 2006, analysis published in Frontiers in Pediatrics indicate.

The trial did not meet the second primary efficacy endpoint of medically attended respiratory syncytial virus-associated lower respiratory tract illness.